LICENSE AGREEMENTLicense Agreement • April 15th, 2005 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS LICENSE AGREEMENT is made as of the 26th day of January, 2005 by and between Formulation Technologies, L.L.C., a Texas limited liability company, d/b/a PharmaForm with offices at 11400 Burnet Road, Building 4, Suite 4010, Austin, Texas 78758 (hereinafter, “PharmaForm” or “Licensor”), and AUXILIUM PHARMACEUTICALS, INC., a Delaware corporation having a principal place of business at 160 W. Germantown Pike, East Norriton, Pennsylvania 19401 (hereinafter, “Auxilium” or” Licensee”). Licensor and Licensee may be referred to as a “Party” or, collectively, as “Parties.”
Employment Agreement Addendum #1Employment Agreement • April 15th, 2005 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations
If Executive’s position is eliminated within the first two (2) years of employment, or if Executive leaves under the conditions described as Termination Without Cause (as defined in Section 2.1) an additional three (3) months of severance shall be paid in accordance with the Employment Agreement entered into on June 1, 2004.
SEPARATION OF EMPLOYMENT AGREEMENT AND MUTUAL GENERAL RELEASESSeparation of Employment Agreement • April 15th, 2005 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
WHEREAS Jane H. Hollingsworth (hereinafter “Ms. Hollingsworth”) has been employed by Auxilium Pharmaceuticals, Inc. (hereinafter “Auxilium”) in the position of Executive Vice President, Secretary and General Counsel; and
AMENDMENT TO RESEARCH AND DEVELOPMENT AGREEMENTResearch and Development Agreement • April 15th, 2005 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment to Research and Development Agreement (the “Amendment”) is entered into as of January 26, 2005 by and between Formulation Technologies, L.L.C., a Texas limited liability company, d/b/a PharmaForm with offices at 11400 Burnet Road, Building 4, Suite 4010, Austin, Texas 78758 (hereinafter, “PharmaForm”), and Auxilium Pharmaceuticals, Inc., a Delaware corporation having a principal place of business at 160 W. Germantown Pike, East Norriton, Pennsylvania 19401 (hereinafter “Auxilium”).
SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASESeparation of Employment Agreement and General Release • April 15th, 2005 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
This Separation Agreement (the “Agreement”) and General Release is entered into as of April 13, 2005, by and between Auxilium Pharmaceuticals, Inc. (“Auxilium”) and Terri B. Sebree (“Executive”).
